Internal Medicine, Gastroenterology · Kansas City, KS
NPI
1336401942
Since 2012
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4000 Cambridge St
Kansas City, KS, 66160
Phone (913) 588-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$66K
659 services
Medicare patients, 2024
424
Average age 71
Drug cost, 2024
$548K
924 prescriptions
Company payments, 2025
$469
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mitesh B Patel was code 45385 (colonoscopy - lesion removal), 130 times for 130 patients. In total Mitesh B Patel billed 659 services in 39 codes, and Medicare paid $66K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45385 Colonoscopy - Lesion Removal | Facility | 130 | 130 | $171.27 | $22K |
| 43239 Upper GI Endoscopy | Facility | 80 | 80 | $58.75 | $4,700 |
| 99222 Hospital E&M - Initial | Facility | 50 | 50 | $95.01 | $4,750 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 44 | 39 | $12.77 | $562 |
| 99214 Office E&M - Established | Office | 41 | 34 | $77.06 | $3,159 |
| 99232 Hospital E&M - Subsequent | Facility | 37 | 32 | $57.75 | $2,137 |
| 45380 Lower GI Endoscopy - Other | Facility | 33 | 33 | $90.89 | $3,000 |
| 43235 Upper GI Endoscopy | Facility | 32 | 31 | $77.21 | $2,471 |
| 99223 Hospital E&M - Initial | Facility | 32 | 32 | $133.45 | $4,270 |
| 99204 Office E&M - New | Office | 23 | 23 | $113.53 | $2,611 |
| 45378 Lower GI Endoscopy - Other | Facility | 23 | 23 | $125.03 | $2,876 |
| 99213 Office E&M - Established | Office | 22 | 22 | $42.33 | $931 |
| 43248 Upper GI Endoscopy | Facility | 18 | 18 | $102.62 | $1,847 |
| 99233 Hospital E&M - Subsequent | Facility | 18 | 13 | $78.75 | $1,418 |
By year: 2022 $62K for 649 services; 2023 $65K for 619 services; 2024 $66K for 659 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mitesh B Patel prescribed most often to Medicare patients was Peg 3350-Electrolyte (Sodium Chloride/Nahco3/Kcl/Peg), with 163 prescriptions and refills. In total Mitesh B Patel wrote 924 Medicare prescriptions that cost $548K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 163 | 165 | 154 | $3,476 |
| Omeprazole Generic | 159 | 371 | 54 | $2,928 |
| Linzess Linaclotide | 68 | 157 | 24 | $84K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 49 | 49 | 46 | $3,268 |
| Famotidine Generic | 49 | 99 | 16 | $631 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 46 | 46 | 46 | $767 |
| Pantoprazole Sodium Generic | 39 | 114 | 14 | $516 |
| Esomeprazole Magnesium Generic | 24 | 47 | Under 11 | $2,620 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 22 | 22 | 20 | $4,690 |
| Motegrity Prucalopride Succinate | 22 | 46 | Under 11 | $24K |
| Dicyclomine Hcl Generic | 20 | 25 | Under 11 | $519 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 20 | 20 | 19 | $315 |
| Creon Lipase/Protease/Amylase | 17 | 23 | Under 11 | $68K |
| Mesalamine Generic | 16 | 41 | Under 11 | $8,928 |
| Lubiprostone Generic | 16 | 16 | Under 11 | $2,724 |
Brand drugs: 261 claims; generic drugs: 663 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mitesh B Patel $469 ($469 in general payments such as food, travel and fees) from 5 companies. The largest payer was Boston Scientific Corporation with $249.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.